Brain Functional Magnetic Resonance Imaging Cue-reactivity Can Predict Baclofen Response in Alcohol Use Disorders

키워드

참고문헌 (62)

1. McLellan AT, "Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation", JAMA, 284, pp.1689~1695 (2000)[DOI]
2. Global status report on alcohol and health 2014, "World Health Organization", World Health Organization, ~ (2014)
3. Swift RM, "Drug therapy for alcohol dependence", N Engl J Med, 340, pp.1482~1490 (1999)[DOI]
4. Zindel LR, "Pharmacotherapy of alcohol use disorders: seventy-five years of progress", J Stud Alcohol Drugs Suppl, 75(Suppl 17), pp.79~88 (2014)[DOI]
5. Soyka M, "Nalmefene for the treatment of alcohol dependence: a current update", Int J Neuropsychopharmacol, 17, pp.675~684 (2014)[DOI]
6. Addolorato G, "Baclofen: a new drug for the treatment of alcohol dependence", Int J Clin Pract, 60, pp.1003~1008 (2006)[DOI]
7. Cruz HG, "Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system", Nat Neurosci, 7, pp.153~159 (2004)[DOI]
8. Muller CA, "High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial", Eur Neuropsychopharmacol, 25, pp.1167~1177 (2015)[DOI]
9. Addolorato G, "Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study", Alcohol Alcohol, 37, pp.504~508 (2002)[DOI]
10. Addolorato G, "Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study", Lancet, 370, pp.1915~1922 (2007)[DOI]
11. Garbutt JC, "Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial", Alcohol Clin Exp Res, 34, pp.1849~1857 (2010)[DOI]
12. Ponizovsky AM, "Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up", J Subst Abuse Treat, 52, pp.24~30 (2015)[DOI]
13. Beraha EM, "Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial", Eur Neuropsychopharmacol, 26, pp.1950~1959 (2016)[DOI]
14. Addolorato G, "Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial", Alcohol Alcohol, 46, pp.312~317 (2011)[DOI]
15. Shukla L, "Correlates of baclofen effectiveness in alcohol dependence", Indian J Psychol Med, 37, pp.370~373 (2015)[DOI]
16. Leggio L, "Effectiveness and safety of baclofen in the treatment of alcohol dependent patients", CNS Neurol Disord Drug Targets, 9, pp.33~44 (2010)[DOI]
17. Leggio L, "A human laboratory pilot study with baclofen in alcoholic individuals", Pharmacol Biochem Behav, 103, pp.784~791 (2013)[DOI]
18. Liu J, "Baclofen for alcohol withdrawal", Cochrane Database Syst Rev, (1) (2011)
19. Morley KC, "Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety", Alcohol Alcohol, 49, pp.654~660 (2014)[DOI]
20. Myrick H, "Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people", Arch Gen Psychiatry, 65, pp.466~475 (2008)[DOI]
21. Braus DF, "Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics", J Neural Transm (Vienna), 108, pp.887~894 (2001)[DOI]
22. Lukas SE, "Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study", Neuroimage, 78, pp.176~185 (2013)[DOI]
23. Kareken DA, "Alcohol-related olfactory cues activate the nucleus accumbens and ventral tegmental area in high-risk drinkers: preliminary findings", Alcohol Clin Exp Res, 28, pp.550~557 (2004)[DOI]
24. Schneider F, "Subcortical correlates of craving in recently abstinent alcoholic patients", Am J Psychiatry, 158, pp.1075~1083 (2001)[DOI]
25. George MS, "Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol- specific cues", Arch Gen Psychiatry, 58, pp.345~352 (2001)[DOI]
26. Myrick H, "Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving", Neuropsychopharmacology, 29, pp.393~402 (2004)[DOI]
27. Beck A, "Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients", Arch Gen Psychiatry, 69, pp.842~852 (2012)[DOI]
28. Sjoerds Z, "Cue reactivity is associated with duration and severity of alcohol dependence: an FMRI study", PLoS One, 9, pp.e84560~ (2014)[DOI]
29. Courtney KE, "Neural substrates of cue reactivity: association with treatment outcomes and relapse", Addict Biol, 21, pp.3~22 (2016)[DOI]
30. Schacht JP, "Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review", Addict Biol, 18, pp.121~133 (2013)[DOI]
31. Goldstein RZ, "Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex", Am J Psychiatry, 159, pp.1642~1652 (2002)[DOI]
32. World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines", World Health Organization, 362~ (1992)
33. Oldfield RC, "The assessment and analysis of handedness: the Edinburgh inventory", Neuropsychologia, 9, pp.97~113 (1971)[DOI]
34. Sullivan JT, "Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar)", Br J Addict, 84, pp.1353~1357 (1989)[DOI]
35. Flannery BA, "Psychometric properties of the Penn Alcohol Craving Scale", Alcohol Clin Exp Res, 23, pp.1289~1295 (1999)[DOI]
36. Holla B, "Visual image-induced craving for ethanol (VICE): development, validation, and a pilot fMRI study", Indian J Psychol Med, 36, pp.164~169 (2014)[DOI]
37. Groefsema M, "The role of social stimuli content in neuroimaging studies investigating alcohol cue-reactivity", Addict Behav, 58, pp.123~128 (2016)[DOI]
38. Power JD, "Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion", Neuroimage, 59, pp.2142~2154 (2012)[DOI]
39. Friston KJ, "Movement-related effects in fMRI time-series", Magn Reson Med, 35, pp.346~355 (1996)[DOI]
40. Cox RW, "FMRI clustering in AFNI: false-positive rates redux", Brain Connect, 7, pp.152~171 (2017)[DOI]
41. Nielsen FA, "Automatic anatomical labeling of Talairach coordinates and generation of volumes of interest via the BrainMap database", Neuroimage, 16(2 Suppl 1), pp.1126~1128 (2002)
42. Brett M, "Region of interest analysis using the MarsBar toolbox for SPM 99", Neuroimage, 16(2 Suppl 1), pp.S497~ (2002)
43. Jasinska AJ, "Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies", Neurosci Biobehav Rev, 38, pp.1~16 (2014)[DOI]
44. Naqvi NH, "The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making", Brain Struct Funct, 214, pp.435~450 (2010)[DOI]
45. Kuhn S, "Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response", Eur J Neurosci, 33, pp.1318~1326 (2011)[DOI]
46. Menon V, "Saliency, switching, attention and control: a network model of insula function", Brain Struct Funct, 214, pp.655~667 (2010)[DOI]
47. Williams ZM, "Human anterior cingulate neurons and the integration of monetary reward with motor responses", Nat Neurosci, 7, pp.1370~1375 (2004)[DOI]
48. Ekhtiari H, "Neuroscience of drug craving for addiction medicine: From circuits to therapies", Prog Brain Res, 223, pp.115~141 (2016)
49. Monti PM, "Toward bridging the gap between biological, psychobiological and psychosocial models of alcohol craving", Addiction, 95(Suppl 2), pp.S229~S236 (2000)[DOI]
50. de Beaurepaire R, "Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patients", Front Psychiatry, 3, pp.103~ (2012)
51. Ameisen O, "Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician", Alcohol Alcohol, 40, pp.147~150 (2005)[DOI]
52. Franklin TR, "Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study", Drug Alcohol Depend, 125, pp.60~66 (2012)[DOI]
53. Franklin TR, "Modulation of resting brain cerebral blood flow by the GABA B agonist, baclofen: a longitudinal perfusion fMRI study", Drug Alcohol Depend, 117, pp.176~183 (2011)[DOI]
54. Myrick H, "The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics", J Clin Psychopharmacol, 30, pp.365~372 (2010)[DOI]
55. Gilman JM, "Subjective and neural responses to intravenous alcohol in young adults with light and heavy drinking patterns", Neuropsychopharmacology, 37, pp.467~477 (2012)[DOI]
56. Gilman JM, "Why we like to drink: a functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol", J Neurosci, 28, pp.4583~4591 (2008)[DOI]
57. Spagnolo PA, "Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients", Alcohol Clin Exp Res, 38, pp.3024~3032 (2014)[DOI]
58. Schacht JP, "Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics", Psychopharmacology (Berl), 227, pp.627~637 (2013)[DOI]
59. Langosch JM, "The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study", J Clin Psychopharmacol, 32, pp.661~665 (2012)[DOI]
60. Mann K, "Predicting naltrexone response in alcohol-dependent patients: the contribution of functional magnetic resonance imaging", Alcohol Clin Exp Res, 38, pp.2754~2762 (2014)[DOI]
61. Benegal V, "India: alcohol and public health", Addiction, 100, pp.1051~1056 (2005)[DOI]
62. Gururaj G, "Alcohol related harm: implications for public health and policy in India", NIMHANS, ~ (2011)

관련 논문AI추천